Sensus Healthcare (SRTS)
(Delayed Data from NSDQ)
$3.28 USD
-0.12 (-3.53%)
Updated Apr 24, 2024 03:59 PM ET
After-Market: $3.29 +0.01 (0.30%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth F Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
SRTS 3.28 -0.12(-3.53%)
Will SRTS be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for SRTS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SRTS
Integer Holdings Corporation (ITGR) Soars to 52-Week High, Time to Cash Out?
New Strong Buy Stocks for February 12th
SRTS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Sensus Healthcare, Inc. (SRTS) Q4 Earnings and Revenues Top Estimates
Earnings Preview: Sensus Healthcare, Inc. (SRTS) Q4 Earnings Expected to Decline
Inogen (INGN) Surges 12.3%: Is This an Indication of Further Gains?
Other News for SRTS
Sensus Healthcare to Host First Quarter 2024 Financial Results and Business Update Conference Call on Thursday, May 9, 2024
Navigating Uncertainty: How Global Crises Threaten Sensus Healthcare’s Growth and Operations
Sensus Healthcare to Participate in the 36th Annual Roth Conference
Sensus Healthcare Launches “Fair Deal Agreement” for its SRT-100 Vision™ at the American Academy of Dermatology Annual Meeting
Sensus Healthcare launches 'Fair Deal Agreement' for SRT-100 Vision